Pathogenesis of cardiotoxicity induced by anthracyclines.
about
Transcriptome profiling of peripheral blood cells identifies potential biomarkers for doxorubicin cardiotoxicity in a rat modelCardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological preventionBeneficial and harmful effects of anthracyclines in the treatment of childhood acute lymphoblastic leukaemia: a systematic review and meta-analysis.Heart repolarization changes after anthracycline therapy in the children with cancerAn integrated control strategy for the fermentation of the marine-derived fungus Aspergillus glaucus for the production of anti-cancer polyketide.Fertility preservation and breast cancer: a reviewCollateral damage: toxic effects of targeted antiangiogenic therapies in ovarian cancer.Biweekly rituximab, cyclophosphamide, vincristine, non-pegylated liposome-encapsulated doxorubicin and prednisone (R-COMP-14) in elderly patients with poor-risk diffuse large B-cell lymphoma and moderate to high 'life threat' impact cardiopathyPattern of cardiac surveillance among patients with lymphoma receiving anthracycline-based chemotherapy.Protective effects of salidroside on epirubicin-induced early left ventricular regional systolic dysfunction in patients with breast cancer.Liposomal daunorubicin as treatment for Kaposi's sarcomaMonitoring of anthracycline-induced cardiotoxicity.Chemotherapy and cardiotoxicityCesium-induced QT-interval prolongation in an adolescent.Predicting and preventing the cardiotoxicity of cancer therapy.Mapping genes that contribute to daunorubicin-induced cytotoxicity.Nonpegylated liposomal doxorubicin in the treatment of B-cell non-Hodgkin's lymphoma: where we stand.Site-specific DNA-doxorubicin conjugates display enhanced cytotoxicity to breast cancer cells.Comparison of doxorubicin cardiotoxicity in pediatric sarcoma patients when given with dexrazoxane versus as continuous infusion.Cardiotoxicity associated with targeting kinase pathways in cancer.Complete heart block in a patient with acute lymphoblastic leukaemia: teicoplanin as a possible cause and review of literature.CMC-544 (inotuzumab ozogamicin), an anti-CD22 immuno-conjugate of calicheamicin, alters the levels of target molecules of malignant B-cells.Long-term follow-up for cardiovascular disease after chemotherapy and/or radiotherapy for breast cancer in an unselected population.5-Fluorouracil induces apoptosis in rat cardiocytes through intracellular oxidative stress.The novel calicheamicin-conjugated CD22 antibody inotuzumab ozogamicin (CMC-544) effectively kills primary pediatric acute lymphoblastic leukemia cells.Delivery of daunorubicin to cancer cells with decreased toxicity by association with a lipidic nanoemulsion that binds to LDL receptors.Barium Titanate Nanoparticles: Highly Cytocompatible Dispersions in Glycol-chitosan and Doxorubicin Complexes for Cancer Therapy.Prevention of doxorubicin-induced cardiomyopathy using targeted MaFGF mediated by nanoparticles combined with ultrasound-targeted MB destruction.An integrated characterization of serological, pathological, and functional events in doxorubicin-induced cardiotoxicity.Cardiotoxicity After Anthracycline Treatment in Survivors of Adult Cancers: Monitoring by USCOM, Echocardiography and Serum Biomarkers.Human herpes virus type 8-associated Kaposi sarcoma in a pediatric liver transplant recipient.Increased mitochondrial emission of reactive oxygen species and calpain activation are required for doxorubicin-induced cardiac and skeletal muscle myopathy.Early cardiac outcomes following contemporary treatment for childhood acute myeloid leukemia: a North American perspective.Anthracycline-induced cardiotoxicity: cardiac monitoring by continuous wave-Doppler ultrasound cardiac output monitoring and correlation to echocardiography.Incidence of cardiovascular disease up to 13 year after cancer diagnosis: A matched cohort study among 32 757 cancer survivorsAnthracycline Therapy Is Associated With Cardiomyocyte Atrophy and Preclinical Manifestations of Heart Disease
P2860
Q33404672-667AE56E-D628-4E89-ACE7-08C327E78897Q33574045-95E1C7C1-0119-447B-B990-EE26A86B80DCQ33615969-93E3875E-3410-4321-B363-82FB25D6E877Q34234872-3C0D9323-6E0F-44D1-A1AB-951B9992F20CQ34250429-0627F420-E313-4006-A4A6-9433D8F1D724Q35106163-DF06CC78-6216-48EF-AC40-EAA211B5ECE7Q35419004-962F2114-B597-40E4-B849-D770FAC6D87BQ35673260-6733D2DF-E5C8-404B-89E9-769363B8D54FQ36163330-5174011C-C274-4AFA-8197-D10CD7E1575EQ36649439-EA701298-DB14-4163-83C4-5E3DFAFDE814Q37004096-BED1000B-5843-440B-92DE-26F6E0A41F8FQ37038186-C5582859-261A-4E9F-8281-AC1BC0930DDDQ37045339-7033086F-E057-4B35-B2BE-D7932FF9A01BQ37227521-F0581D4D-C381-4481-A4AC-EE9AF339B21CQ37230408-7783A7D2-6FA0-47EC-9CC5-D6374753C144Q37328312-79DB8C98-9F44-4DA3-A5A5-24252E9B08E1Q37411182-C74F6C9A-951D-4A95-91EB-F5C04C66377DQ37697041-F3D2FDAF-46B9-474F-9449-CB32C8D3AF2AQ37783289-9996B1A1-4421-424B-9155-8ACFB9F33B7CQ37823035-EA78A2C8-08C2-4DDF-B2F7-C3543B2DCDF6Q38070722-B54D9C32-869B-40E7-9E9D-FEE3CCD96C1DQ38355000-374E56F3-AF58-4012-B763-5D74AD8262ACQ39241736-CF27D220-B44E-4B16-ADFF-CB969FB8BD43Q39311982-50C6E774-C780-43EF-8240-BDEAB954A929Q39484177-4F019EE9-40C1-4877-9AA1-9BE263402B9FQ39936738-03151FB2-AFAA-440A-96E2-7E08EF9CE596Q41562801-FAB6DAB3-DEC8-47A9-B0E4-EF3B1592C895Q42241172-EAE47587-C3E5-4A99-AC1B-75C78E4AE178Q42706225-221D5C8A-230A-49D6-A625-492DA8A13331Q43807501-70B2CA41-5FA7-4CD2-A2B2-0EFDAE1B5958Q45137299-69D249B0-1268-4B8E-9AEC-F10C7B1FD376Q46778817-4307234A-BE5E-440E-ACE3-F95B91BF8D58Q46904082-CB6A53A2-B91A-4D99-AD71-A528DC2C9E08Q51319986-98369A39-940B-4B46-ACB4-3A72A87F937CQ58736150-7F6220E9-C79C-4802-A8FB-1F32302C3809Q58803993-4D91C81F-09AB-4968-91B0-DF11A8AFD1CC
P2860
Pathogenesis of cardiotoxicity induced by anthracyclines.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Pathogenesis of cardiotoxicity induced by anthracyclines.
@ast
Pathogenesis of cardiotoxicity induced by anthracyclines.
@en
type
label
Pathogenesis of cardiotoxicity induced by anthracyclines.
@ast
Pathogenesis of cardiotoxicity induced by anthracyclines.
@en
prefLabel
Pathogenesis of cardiotoxicity induced by anthracyclines.
@ast
Pathogenesis of cardiotoxicity induced by anthracyclines.
@en
P1433
P1476
Pathogenesis of cardiotoxicity induced by anthracyclines.
@en
P2093
Perry Elliott
P356
10.1053/J.SEMINONCOL.2006.04.020
P433
P577
2006-06-01T00:00:00Z